| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Illumina, Inc. (ILMN) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 38 sells. ILMN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 3.50M | $565.17M | - | |
| Dir | 2.83M | $456.78M | -669,596 | |
| CEO | 82.1K | $13.25M | - | |
| VP | 41.9K | $6.77M | - | |
| VP | 33.0K | $5.33M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 7, 2018 | Stapley Marc60 | EVP Strategy &Corp Developmt | Sell | 1,000 | $336.68 | $336,679.53 | -4.4% | |
| Nov 5, 2018 | Van Oene Mark79 | SVP Chief Commercial Officer | Sale+OE | 6,835 | $326.11 | $2,228,950.46 | -6.5% | |
| Nov 1, 2018 | Desouza Francis A | President And CEO | Sell | 2,100 | $310.85 | $652,788.16 | -0.7% | |
| Nov 1, 2018 | Epstein Robert S | Director | Sale+OE | 1,346 | $311.86 | $419,763.56 | -20.9% | |
| Oct 24, 2018 | Flatley Jay T47 | Director | Sell | 3,300 | $310.58 | $1,024,914.00 | -0.9% | |
| Oct 10, 2018 | Ronaghi Mostafa | Sr VP &CTO | Sale+OE | 10,000 | $311.84 | $3,118,423.77 | -0.9% | |
| Oct 10, 2018 | Flatley Jay T47 | Director | Sell | 3,300 | $321.58 | $1,061,214.00 | -0.8% | |
| Oct 1, 2018 | Desouza Francis A | President And CEO | Sell | 2,100 | $369.61 | $776,183.00 | -1.0% | |
| Oct 1, 2018 | Epstein Robert S | Director | Sale+OE | 1,346 | $369.15 | $496,875.90 | -19.8% | |
| Sep 26, 2018 | Flatley Jay T47 | Director | Sell | 3,300 | $360.81 | $1,190,673.00 | -0.8% |